NCT07262164 2026-03-25
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Virogin Biotech Ltd.
Phase 1 Recruiting
Virogin Biotech Ltd.
Minghui Pharmaceutical (Hangzhou) Ltd
Virogin Biotech Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd